Basal cell carcinoma of the prostate is an aggressive tumor with frequent loss of PTEN expression and overexpression of EGFR
- 1 June 2015
- journal article
- Published by Elsevier in Human Pathology
- Vol. 46 (6) , 805-812
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Mutational Landscape of Prostate CancerEuropean Urology, 2013
- Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literatureWorld Journal of Surgical Oncology, 2013
- Basaloid carcinoma of the prostate: A literature review with case reportIndian Journal of Urology, 2012
- Targeted therapy in prostate cancerHistopathology, 2011
- ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal originLaboratory Investigation, 2011
- Basal cell carcinoma of the prostate: unusual subtype of prostatic carcinomaInternational Journal of Clinical Oncology, 2010
- Basal cell carcinoma of the prostate: Report of a case and review of the published reportsInternational Journal of Urology, 2008
- Adenoid cystic/basal cell carcinoma of the prostate strongly expresses HER-2/neuJournal of Clinical Pathology, 2006
- Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expressionJournal of Clinical Pathology, 2005
- Adenoid cystic or “salivary gland” carcinomas of prostateUrology, 1975